You need Java to see this applet.

Archives Headlines 2006 NanoPharmaceuticals

A Study Outline Parameters for Encapsulating Drugs in Nanoparticles SRI International to Conduct Preclinical Studies of Cancer Drug for Taiwan Liposome Company Maelor and Plethora Solutions enter into a licensing agreement for micelle nanotechnology Nanotechnology Holds Promise of Revolutionising European Drug Discovery Markets.   A Key Technical Breakthrough in Lyophilized (Dry Powder) Liposomal-Based siRNA Formulation. Injectable Nanotechnology Approved for Phase III Clinical Trial, to Treat Diabetis Related Blinding Promising Early Clinical Results for Long Acting PEG-Liposomal Product for Hemophilia   Per-clinical studies of Cisplatin-incorporating polymeric micelles of NanoCarrier Co Ltd showed reduced toxicity. NIH is providing funding for the clinical development of VivaGel™ . First nanotechnology based consumables are recalled due to their pulmonary toxicity. Scientist from Israel conducting a Phase II clinic trial to evaluated antibacterial effect nanoparticles:   UCSF scientist develop novel nanoparticles for delivery of drugs to brain: A Novel biocmpatible Nanocapsules are designed by scientist

VCs to Nanotech: Don't Call Us!:  Medical and Pharmaceutical sector received highest VC investment (21% of total investment) world wide.2/27/2006 Indian President Kalam’s address at Indo-US Nanotechnology Conclave VIVAGEL™ receives fast track status from FDA Merck KGaA acquires full US rights to BLP25 liposome cancer vaccine Elan and EntreMed execute license agreement for proprietary NanoCrystal® technology Blp25 liposome vaccine phase 2 study interim results indicate no safety concerns with reformulated vaccine Dendritic Nanotechnologies’ priostar family of dendrimers receives “Technology Innovation of the Year” award NanoViricides, Inc. receives additional safety data Nanotechnology regulation needed, critics say Broadening opportunities for nanotechnology in drug discovery and research---Report

About us | Advertising | Contact us © 2005-2006 NanoPharmaceuticals.org. All rights reserved. No part of this Internet site may be reproduced without prior written permission of the copyright holder. Terms & Disclaimer